User login
Primary tabs
Concerned about African Swine Fever? Newport Laboratories does not use any raw materials from countries identified by the USDA as potential carriers of foreign animal diseases, including China.
UPGRADE YOUR TOOLBOX
HERDPOINT, which is powered by GVL (GlobalVetLink) and available exclusively to customers of Newport Laboratories, simplifies isolate management and improves the efficiency of the nonadjacent approval process.
Filling in the Gaps with Custom-Made Vaccines
There are economic costs associated with some key bovine diseases.
Custom-made vaccines can help protect your herd from these diseases and reduce your economic losses.
Pinkeye Educational Modules
Newport Laboratories is proud to present four interactive educational modules about Pinkeye in cattle.
Click on the button below to view the modules on an external site.
Press Releases
New One-Dose Adjuvant Saves Time, Cost by Removing Need for Booster Shots
New One-Dose Adjuvant Saves Time, Cost by Removing Need for Booster Shots
WORTHINGTON, Minn. (Oct. 30, 2019) — Newport Laboratories, Inc., a leader in custom-made vaccines, today launches Bio One™, a new, proprietary one-dose adjuvant that helps reduce time, labor and expense by removing the need for booster shots.
Adjuvants: The Biggest Variable in a Vaccine
There are two basic ingredients in killed vaccines: antigens and adjuvants. While antigens are well understood, there’s far less understanding of the critical role adjuvants play in vaccines’ ability to do their job. But not all adjuvants are the same, and identifying which adjuvant has the right properties to help solve a herd’s health challenges can give producers and veterinarians peace of mind that they’re giving the best possible vaccine to their animals.
Pinkeye: New Challenges Call for New Solutions
Cattle herds exposed to infectious bovine keratoconjunctivitis, more commonly known as pinkeye, are at risk of lower calf-growth rate, potential blindness and permanent damage if left untreated.1 It’s estimated that pinkeye causes annual losses of more than $150 million in the United States, affecting over 10 million calves.1
With an emerging species of pinkeye bacteria overtaking the previously predominant species, controlling this increasingly complex disease is challenging for many producers and veterinarians. But there are tools that can help.
3 Key Advancements in the Fight Against Strep
As producers continue to reduce the amount of antibiotics given to their herds, many are looking to other options to fight Streptococcus suis, more commonly known as Strep suis.
The pathogen is one of the primary causes of bacterial meningitis in pigs,1 and can cause illness at any stage of production, with associated mortality rates of up to 20 percent.2 With infections often existing subclinically and nearly 100 percent of pigs serving as carriers of the bacteria,3Strep suis is a key concern for many producers.
A New Era of